echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The first domestically produced "recombinant human coagulation factor Ⅷ" was approved for listing from Shenzhou Cell Engineering

    The first domestically produced "recombinant human coagulation factor Ⅷ" was approved for listing from Shenzhou Cell Engineering

    • Last Update: 2021-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    July 23, NMPA publish this document, Shenzhou Cell Engineering "recombinant human coagulation factor Ⅷ" (codename: SCT800) approved the listing, is indicated for hemophilia hemorrhage control and prevention


    From: NMPA official website

    Hemophilia A is a coagulation dysfunction caused by the lack of coagulation eight factor protein.


    2018, the number of patients with hemophilia worldwide about 774,000, the number of patients in China about 14 million, of which about 85% of the hemophilia patients


    Factor VIII is a special medicine and essential medicine for patients with hemophilia A.


    The eight factors of coagulation in China are mostly extracted from human plasma, but due to the shortage of human plasma supply, the production capacity of plasma to extract the eight factors is very limited


    From the Insight database (http://db.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.